FDA Threatens To Pull Blood Pressure Drug
The U.S. Food and Drug Administration said Monday it was considering withdrawing its approval of the drug midodrine hydrochloride because Shire PLC and generic-drug manufacturers did not perform clinical benefits studies...To view the full article, register now.
Already a subscriber? Click here to view full article